Gabapentin is approved for seizures and post-herpetic neuralgia; gabapentin enacarbil is approved for restless legs syndrome.

A commonly prescribed pain medication—gabapentin—often considered a safer alternative to opioids for those who suffer from low back pain is now under scrutiny after being linked to increased risks of ...

A large U.S. medical records study has found that adults prescribed gabapentin six or more times for chronic low back pain ...

Gabapentin is expected to reach $4.95 billion by 2033, growing at a 6.12% CAGR . Similarly, the pregabalin market is forecast to grow to $2.2 billion by 2032 , driven by the need for chronic pain ...

Gabapentin is expected to reach $4.95 billion by 2033, growing at a 6.12% CAGR . Similarly, the pregabalin market is forecast to grow to $2.2 billion by 2032 , driven by the need for chronic pain ...

References: He Y, Mo L, Li J, Lu D, Niu J, Li Y, Zeng Q, Gao Y. Association of perioperative initiation of gabapentin versus pregabalin with kidney function: a target trial emulation study. Front ...

Gabapentin is expected to reach $4.95 billion by 2033, growing at a 6.12% CAGR . Similarly, the pregabalin market is forecast to grow to $2.2 billion by 2032 , driven by the need for chronic pain ...

The review linked gabapentin or pregabalin to 49 cases of respiratory depression from 2012 to 2017. In 92% of those cases, the person had a respiratory risk factor, and 12 of the 49 people died.

Pregabalin is used to treat conditions including epilepsy, nerve pain and anxiety on the NHS, external. It comes as tablets, capsules or in liquid form, and may be called Alzain, Axalid or Lyrica ...